131 related articles for article (PubMed ID: 17411317)
1. HIV and cardiovascular disease: contribution of HIV-infected macrophages to development of atherosclerosis.
Bukrinsky M; Sviridov D
PLoS Med; 2007 Jan; 4(1):e43. PubMed ID: 17411317
[No Abstract] [Full Text] [Related]
2. Early increases in concentrations of total, LDL, and HDL cholesterol in HIV-infected children following new exposure to antiretroviral therapy.
Sztam KA; Jiang H; Jurgrau A; Deckelbaum RJ; Foca MD
J Pediatr Gastroenterol Nutr; 2011 Apr; 52(4):495-8. PubMed ID: 21206378
[TBL] [Abstract][Full Text] [Related]
3. [Should I worry if my cholesterol is high?].
Davis MA
Sidahora; 2002; (1):19. PubMed ID: 12772660
[No Abstract] [Full Text] [Related]
4. Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy.
Riddler SA; Li X; Chu H; Kingsley LA; Dobs A; Evans R; Palella F; Visscher B; Chmiel JS; Sharrett A
HIV Med; 2007 Jul; 8(5):280-7. PubMed ID: 17561873
[TBL] [Abstract][Full Text] [Related]
5. [Physiopathology of cardiovascular disease in HIV-infected patients].
Alonso-Villaverde Lozano C
Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():33-9. PubMed ID: 20172413
[TBL] [Abstract][Full Text] [Related]
6. A pilot randomized trial comparing an intensive versus a standard intervention in stable HIV-infected patients with moderate-high cardiovascular risk.
Masiá M; Bernal E; Padilla S; García N; Escribano JC; Martínez E; Gutiérrez F
J Antimicrob Chemother; 2009 Sep; 64(3):589-98. PubMed ID: 19625372
[TBL] [Abstract][Full Text] [Related]
7. Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients.
Badiou S; Thiebaut R; Aurillac-Lavignolle V; Dabis F; Laporte F; Cristol JP; Mercie P;
J Infect; 2008 Jul; 57(1):47-54. PubMed ID: 18554723
[TBL] [Abstract][Full Text] [Related]
8. Does HIV cause cardiovascular disease?
Carr A; Ory D
PLoS Med; 2006 Nov; 3(11):e496. PubMed ID: 17132070
[TBL] [Abstract][Full Text] [Related]
9. Growing up with perinatal HIV infection: time for a HAART to heart.
Siberry GK; Joyner M; Hutton N
J Pediatr; 2008 Oct; 153(4):456-7. PubMed ID: 18847617
[No Abstract] [Full Text] [Related]
10. Lipid profiles of Thai adult HIV-infected patients receiving protease inhibitors.
Hiransuthikul N; Hiransuthikul P; Kanasook Y
Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):69-77. PubMed ID: 17539249
[TBL] [Abstract][Full Text] [Related]
11. Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophage.
Li K; Yao W; Zheng X; Liao K
Cell Res; 2009 Aug; 19(8):1006-17. PubMed ID: 19546885
[TBL] [Abstract][Full Text] [Related]
12. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
[TBL] [Abstract][Full Text] [Related]
13. Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
Nguyen ST; Eaton SA; Bain AM; Rahman AP; Payne KD; Bedimo R; Herrington JD; Maclayton DO; Rodriguez-Barradas MC; Busti AJ
Pharmacotherapy; 2008 Mar; 28(3):323-30. PubMed ID: 18294112
[TBL] [Abstract][Full Text] [Related]
14. Effects of nevirapine, compared with lamivudine, on lipids and lipoproteins in HIV-1-uninfected newborns: the stopping infection from mother-to-child via breast-feeding in Africa lipid substudy.
Sankatsing RR; Wit FW; Pakker N; Vyankandondera J; Mmiro F; Okong P; Kastelein JJ; Lange JM; Stroes ES; Reiss P
J Infect Dis; 2007 Jul; 196(1):15-22. PubMed ID: 17538878
[TBL] [Abstract][Full Text] [Related]
15. Cord blood lipids in infants born to HIV-1-infected women treated with combination antiretroviral therapy.
Melvin AJ; Kang M; Hitti J; Livingston E; Cohn SE; Stocker V; Ross AC; Watts H; McComsey GA
Antivir Ther; 2008; 13(3):349-55. PubMed ID: 18572747
[TBL] [Abstract][Full Text] [Related]
16. Ezetimibe lowers cholesterol levels.
Proj Inf Perspect; 2009 Mar; (48):13. PubMed ID: 19492464
[No Abstract] [Full Text] [Related]
17. Review on structured treatment interruptions (STIs).
Hirschel B
Top HIV Med; 2007; 15(1):17; author reply 17. PubMed ID: 17471685
[No Abstract] [Full Text] [Related]
18. [Reverse cholesterol transport processes and their role in artherosclerosis regression].
Chachaj A; Drozdz K; Szuba A
Postepy Biochem; 2008; 54(3):301-7. PubMed ID: 19112829
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow-derived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice.
Pennings M; Hildebrand RB; Ye D; Kunne C; Van Berkel TJ; Groen AK; Van Eck M
Cardiovasc Res; 2007 Oct; 76(1):175-83. PubMed ID: 17560559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
